These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7168715)

  • 1. Biofeedback therapy for spastic dysphonia.
    Watanabe H; Komiyama S; Ryu S; Kannae S; Matsubara H
    Auris Nasus Larynx; 1982; 9(3):183-90. PubMed ID: 7168715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantation of a recurrent laryngeal nerve stimulator for the treatment of spastic dysphonia.
    Friedman M; Toriumi DM; Grybauskas VT; Applebaum EL
    Ann Otol Rhinol Laryngol; 1989 Feb; 98(2):130-4. PubMed ID: 2783840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic laryngeal muscle activity in a spastic dysphonia patient.
    Shipp T; Izdebski K; Reed C; Morrissey P
    J Speech Hear Disord; 1985 Feb; 50(1):54-9. PubMed ID: 3974213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures for the selection of spastic dysphonia patients for recurrent laryngeal nerve section.
    Ludlow CL; Naunton RF; Bassich CJ
    Otolaryngol Head Neck Surg; 1984 Feb; 92(1):24-31. PubMed ID: 6422412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spasmodic dysphonia.
    Rosenfield DB
    Adv Neurol; 1988; 50():537-45. PubMed ID: 3400508
    [No Abstract]   [Full Text] [Related]  

  • 6. The present status of adductor spastic dysphonia.
    Stoicheff ML
    J Otolaryngol; 1983 Oct; 12(5):311-4. PubMed ID: 6644860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory distress after recurrent laryngeal nerve sectioning for adductor spastic dysphonia.
    Salassa JR; DeSanto LW; Aronson AE
    Laryngoscope; 1982 Mar; 92(3):240-5. PubMed ID: 7070166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electromyographic biofeedback training with patients exhibiting a hyperfunctional voice disorder.
    Stemple JC; Weiler E; Whitehead W; Komray R
    Laryngoscope; 1980 Mar; 90(3):471-6. PubMed ID: 7359968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spastic dysphonia: a patient profile of 200 cases.
    Izdebski K; Dedo HH; Boles L
    Am J Otolaryngol; 1984; 5(1):7-14. PubMed ID: 6534197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting the side of recurrent laryngeal nerve section for spastic dysphonia.
    Izdebski K; Dedo HH
    Otolaryngol Head Neck Surg; 1981; 89(3 Pt 1):423-6. PubMed ID: 6791104
    [No Abstract]   [Full Text] [Related]  

  • 11. Electromyographic findings in focal laryngeal dystonia (spastic dysphonia).
    Blitzer A; Lovelace RE; Brin MF; Fahn S; Fink ME
    Ann Otol Rhinol Laryngol; 1985; 94(6 Pt 1):591-4. PubMed ID: 4073737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vivo canine model for testing treatment effects in laryngeal hyperadduction disorders.
    Green DC; Berke GS
    Laryngoscope; 1990 Nov; 100(11):1229-35. PubMed ID: 2233089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection.
    Rodriquez AA; Ford CN; Bless DM; Harmon RL
    Electromyogr Clin Neurophysiol; 1994; 34(7):403-7. PubMed ID: 7859668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
    Brin MF; Blitzer A; Fahn S; Gould W; Lovelace RE
    Mov Disord; 1989; 4(4):287-96. PubMed ID: 2811888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of spastic dysphonia without nerve section.
    Friedman M; Toriumi DM; Grybauskas V; Applebaum EL
    Ann Otol Rhinol Laryngol; 1987; 96(5):590-6. PubMed ID: 3499837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in spasmodic dysphonia. Neurologic and voice findings.
    Pool KD; Freeman FJ; Finitzo T; Hayashi MM; Chapman SB; Devous MD; Close LG; Kondraske GV; Mendelsohn D; Schaefer SD
    Arch Neurol; 1991 Mar; 48(3):305-9. PubMed ID: 2001189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Voice Therapy on Laryngeal Motor Units During Phonation in Chronic Superior Laryngeal Nerve Paresis Dysphonia.
    Kaneko M; Hitomi T; Takekawa T; Tsuji T; Kishimoto Y; Hirano S
    J Voice; 2018 Nov; 32(6):729-733. PubMed ID: 28967588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory investigation of the abnormal voice.
    Briant TD; Blair RL; Cole P; Singer L
    J Otolaryngol; 1983 Oct; 12(5):285-90. PubMed ID: 6644856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of topical lidocaine in the treatment of muscle tension dysphonia.
    Dworkin JP; Meleca RJ; Simpson ML; Garfield I
    J Voice; 2000 Dec; 14(4):567-74. PubMed ID: 11130113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMG biofeedback treatment of pediatric hyperfunctional dysphonia.
    Allen KD; Bernstein B; Chait DH
    J Behav Ther Exp Psychiatry; 1991 Jun; 22(2):97-101. PubMed ID: 1757596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.